Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection

Biomedical Chromatography

Volumn 24, Issue 6, 2010, Pages 626-631

  Hubbard, K Elaine ^a   Wells, Amy ^a   Owens, Thandranese S ^a   Tagen, Michael ^a   Fraga, Charles H ^a   Stewart, Clinton F ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cerebrospinal fluid (CSF); Electrochemical detection (ED); High performance liquid chromatography (HPLC); Neurotransmitter

Indexed keywords

AMINES; ANTIOXIDANTS; BRAIN; CEREBROSPINAL FLUID; CHEMICAL DETECTION; METABOLITES; NEUROPHYSIOLOGY; SODIUM COMPOUNDS;

ANALYTES; CEREBROSPINAL FLUID; DOPAMINE; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOVANILLIC ACID; ISOCRATIC; NEUROTRANSMITTER;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

5 HYDROXYINDOLEACETIC ACID; ACETONITRILE; ANTIOXIDANT; CYCLOPHOSPHAMIDE; DIHYDROXYINDOLPHENYLACETIC ACID; DOPAMINE; EDETIC ACID; HOMOVANILLIC ACID; PHENYLACETIC ACID DERIVATIVE; SEROTONIN; TETRAHYDROFURAN; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CEREBROSPINAL FLUID LEVEL; CHILDHOOD CANCER; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MEDULLOBLASTOMA; PROTEIN DEGRADATION; QUALITY CONTROL; SENSITIVITY ANALYSIS; THERMOSTABILITY;

EID: 77952775206     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1338     Document Type: Article

References (24)

1. Baig S, Halawa I and Qureshi GA. High performance liquid chromatography as a tool in the definition of abnormalities in monoamine and tryptophan metabolites in cerebrospinal fluid from patients with neurological disorders. Biomedical Chromatography 1991; 5: 108-112.
2. Brautigam C, Wevers RA, Jansen RJ, Smeitink JA, de Rijk-van Andel JF, Gabreels FJ and Hoffmann, GF. Biochemical hallmarks of tyrosine hydroxylase deficiency. Clinical Chemistry 1998; 44: 1897-1904. (Pubitemid 28405753)
3. Brown RT, Madan-Swain A, Walco GA, Cherrick I, Ievers CE, Conte PM, Vega R, Bell B and Lauer SJ. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. Journal of Pediatric Psychology 1998; 23: 333-340. (Pubitemid 28432425)
4. Castellanos FX, Elia J, Kruesi MJ, Gulotta CS, Mefford IN, Potter WZ, Ritchie GF and Rapoport JL. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Research 1994; 52: 305-316. (Pubitemid 24225428)
5. DeLong R, Friedman H, Friedman N, Gustafson K and Oakes J. Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. Journal of Child Neurology 1992; 7: 462-463.
6. Dennis M, Spiegler BJ, Hetherington CR and Greenberg ML. Neuropsychological sequelae of the treatment of children with medulloblastoma. Journal of Neurooncology 1996; 29: 91-101. (Pubitemid 26193508)
7. Filloux FM, Adair J and Narang N. The temporal evolution of striatal dopamine receptor binding and mRNA expression following hypoxia-ischemia in the neonatal rat. Brain Research and Developmental Brain Research 1996; 94: 81-91. (Pubitemid 26227586)
8. Fujino K, Yoshitake T, Kehr J, Nohta H and Yamaguchi M. Simultaneous determination of 5-hydroxyindoles and catechols by high-performance liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine. Journal of Chromatography A 2003; 1012: 169-177. (Pubitemid 37297597)
9. Geracioti TD, Keck PE, Ekhator NN, West SA, Baker DG, Hill KK, Bruce AB and Wortman MD. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid. Biological Psychiatry 1998; 44: 228-233.
10. Hanna GL, Ornitz EM and Hariharan M. Urinary catecholamine excretion and behavioral differences in ADHD and normal boys. Journal of Child and Adolescent Psychopharmacology 1996; 6: 63-73. (Pubitemid 26168919)
11. Hopewell JW and van der Kogel AJ. Pathophysiological mechanisms leading to the development of late radiation-induced damage to the central nervous system. Frontiers of Radiation and Therapeutic Oncology 1999; 33: 265-275.
12. Kankaanpaa A, Meririnne E, Ariniemi K and Seppala T. Oxalic acid stabilizes dopamine, serotonin, and their metabolites in automated liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Science Applications 2001; 753: 413-419. (Pubitemid 32217744)
13. Kondoh T, Lee SH and Low WC. Alterations in striatal dopamine release and reuptake under conditions of mild, moderate, and severe cerebral ischemia. Neurosurgery 1995; 37: 948-954.
14. Mulhern RK, Reddick WE, Palmer SL, Glass JO, Elkin TD, Kun LE, Taylor J, Langston J and Gajjar A. Neurocognitive deficits in medulloblastoma survivors and white matter loss. Annals of Neurology 1999; 46: 834-841.
15. Patel BA, Arundell M, Parker KH, Yeoman MS and O'Hare D. Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B: Analytical Technology in Biomedicine and Life Sciences 2005; 818: 269-276. (Pubitemid 40340121)
16. Reddick WE, White HA, Glass JO, Wheeler GC, Thompson SJ, Gajjar A, Leigh L and Mulhern RK. Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer (Journal) 2003; 97: 2512-2519. (Pubitemid 36542491)
17. Rodgers J, Horrocks J, Britton PG and Kernahan J. Attentional ability among survivors of leukaemia. Archives of Diseases of Childhood 1999; 80: 318-323.
18. Schultheiss TE, Kun LE, Ang KK and Stephens LC. Radiation response of the central nervous system. International Journal of Radiation Oncology, Biology and Physics 1995; 31: 1093-1112.
19. Soderstrom H, Blennow K, Sjodin AK and Forsman A. New evidence for an association between the CSF HVA:5-HIAA ratio and psychopathic traits. Journal of Neurolog, Neurosurgery and Psychiatry 2003; 74: 918-921. (Pubitemid 36782996)
20. Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, Reddick WE, Gajjar A, Merchant T, Pui CH, Hudson MM and Mulhern RK. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. Journal of Clinical Oncology 2001; 19: 1802-1808. (Pubitemid 32230883)
21. Thorre K, Pravda M, Sarre S, Ebinger G and Michotte Y. New antioxidant mixture for long term stability of serotonin, dopamine and their metabolites in automated microbore liquid chromatography with dual electrochemical detection. Journal of Chromatography B: Biomedical Science Applications 1997; 694: 297-303. (Pubitemid 27289502)
22. Vaarmann A, Kask A and Maeorg U. Novel and sensitive high-performance liquid chromatographic method based on electrochemical coulometric array detection for simultaneous determination of catecholamines, kynurenine and indole derivatives of tryptophan. Journal of Chromatography B: Analytical Technology in Biomedicine and Life Sciences 2002; 769: 145-153. (Pubitemid 34188389)
23. Yoshitake T, Fujino K, Kehr J, Ishida J, Nohta H and Yamaguchi M. Simultaneous determination of norepinephrine, serotonin, and 5-hydroxyindole-3-acetic acid in microdialysis samples from rat brain by microbore column liquid chromatography with fluorescence detection following derivatization with benzylamine. Analytical Biochemistry 2003; 312: 125-133. (Pubitemid 36151122)
24. Zhang W, Cao X, Xie Y, Ai S, Jin L and Jin J. Simultaneous determination of the monoamine neurotransmitters and glucose in rat brain by microdialysis sampling coupled with liquid chromatography-dual electrochemical detector. Journal of Chromatography B: Analytical Technology in Biomedicine and Life Sciences 2003; 785: 327-336. (Pubitemid 36126173)